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Abstract 14 
The Schmallenberg virus (SBV) caused a large scale epidemic in Europe from 2011–2013 15 
infecting ruminants and causing fetal deformities after infection of pregnant animals. The main 16 
impacts of the virus were financial losses due to animal, meat and semen trade restrictions.  17 
Even though effective vaccines were produced, their uptake was never high. This along with the 18 
subsequent decline in new SBV infections and natural replacement of previously exposed livestock 19 
has resulted in a drop in the number of protected animals. Recent surveillance has found a large 20 
population of naïve animals currently present in Europe and the virus circulating at a low level. 21 
These changes in animal status in combination with favourable conditions for the insect vectors 22 
may open the door to the re-emergence of the virus and another large-scale outbreak in Europe. 23 
This review details the potential and preparedness for SBV re-emergence in Europe, discusses 24 
possible co-ordinated sentinel monitoring programmes both for ruminant seroconversion and the 25 
presence of virus in the insect vectors and provides an overview of the economic impact associated 26 
with diagnosis, control and the effect of non-vaccination.  27 
 28 
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Introduction 32 
Schmallenberg virus (SBV) is an Orthobunyavirus of the Simbu serogroup that was 33 
responsible for a large-scale outbreak of fetal deformities in lambs and calves in Northern Europe in 34 
2011–13 (Hoffmann et al., 2012). The virus causes little or no disease in adult animals but displays 35 
a distinct tropism for the central nervous system of lambs and calves infected in utero leading to a 36 
range of distinctive deformities including hydrocephalus and arthrogryposis (Bayrou et al., 2014; 37 
Peperkamp et al., 2015). In the years since its initial emergence, SBV appears to have settled to a 38 
low-level endemic circulation. Considerable research into SBV and its epidemiology (Helmer et al., 39 
2013; Luttikholt et al., 2014; Veldhuis et al., 2014) has been conducted since its discovery, 40 
including the development of commercial vaccines (Kraatz et al., 2015). However, several years of 41 
little or no clinical disease and a lack of clarity about the economic impacts have resulted in very 42 
poor uptake of the vaccine. It is also unclear what conditions could result in a further large scale 43 
outbreak, but it is likely that herd-level immunity to the virus at a European and a local level has 44 
decreased, creating the potential conditions for another outbreak of fetal deformities. This review 45 
summarises the current state of preparedness for further SBV outbreaks in Europe.  46 
 47 
First detection and initial spread of SBV 48 
SBV was first detected in Europe in the beginning of September 2011. Infections appeared 49 
near simultaneously in 2011 in neighbouring countries Germany, the Netherlands and Belgium. By 50 
February 2012 and May 2012 peaks in infections in sheep and cattle respectively had been 51 
identified. At the height of the outbreak in 2013, SBV cases were reported in 13,846 herds in 29 52 
countries, with 8730 being laboratory confirmed. It is difficult to calculate the actual numbers of 53 
animals affected as only herd level data were collected and reported in many countries (Afonso et 54 
al., 2014). In the UK, seroprevalence in the most affected counties by the end of 2013 was 73%. 55 
However, in other UK areas, this figure was less than 50% suggesting there were a large number of 56 
animals still at risk (King et al., 2015). Circulation re-occurred the next winter and spring, though at 57 
a lower peak than in 2011/12, probably due to large numbers of animals with pre-existing immunity 58 
(EFSA, 2012a). 59 
 60 
SBV spreads extremely rapidly, estimated from EU Nomenclature of Territorial Units for 61 
Statistics (NUTS) to be 6 days from region to region (Sedda and Rogers, 2013). It has been reported 62 
in climate ranges from the Mediterranean basin (Italy and Spain) to more than lattitude 60 ° north 63 
(Norway) (Balseiro et al., 2015; Monaco et al., 2013; Wisløff et al., 2014). Spread of the virus has 64 
tended to be from close-by infected regions to the next region, rarely exceeding 200 km at a time 65 
(Afonso et al., 2014). Interestingly, modelling the spread of SBV using mathematical methods has 66 
replicated the spread of SBV across Europe, uncovering a high vector competence and high 67 
replication rate for temperatures common in Europe (16-34°C) (EFSA, 2014; Gubbins et al., 68 
2014a). 69 
 70 
It is still unclear where the virus originated from but at least two studies have demonstrated 71 
SBV cross reactive antibodies (along with several other Simbu group viruses) in cattle in Africa 72 
prior to or after the European outbreak. In the Middle East a Simbu serogroup virus related to Aino 73 
virus was found recently, causing clinical signs similar to SBV in infected ruminants (Abutarbush et 74 
al., 2015). Several historical and recent reports have highlighted that viruses from the Simbu group, 75 
many of which have teratogenic potential, circulate within the Mediterranean basin (Lievaart-76 
Peterson et al., 2012; Azkur et al., 2013; Chaintoutis et al., 2014; Yilmaz et al., 2014).  77 
At the height of the original outbreak in Europe, herds in Northern Europe were reporting 78 
essentially all animals seroconverting to the virus, 98.5–99.8% in adult cattle and 89% in sheep 79 
(Méroc et al., 2013; Veldhuis et al., 2013) at herd level. 80 
 81 
Virus transmission 82 
SBV, like many other Bunyaviruses, is an arbovirus, i.e. it is transmitted via arthropod 83 
vectors. The fact that the virus relies on vector transmission limits antigenic drift as mutations that 84 
could confer advantages in final host replication could be disadvantageous in the vector. This 85 
bottleneck has also been seen in other RNA viruses that depend on mosquito vectors, such as 86 
Venezuelan equine encephalitis virus (Forrester et al., 2012). SBV has also been found to have a 87 
low mutation rate both in vitro, even when passaged 10 times, and in vivo (Hoffmann et al., 2015). 88 
Several field studies of virus variability have also demonstrated that the virus is relatively stable 89 
over time (Coupeau et al 2016; Izzo et al., 2016).  90 
 91 
Direct horizontal transmission by contact has not been detected, even when infected cows 92 
were kept in close proximity to uninfected cows (Wernike, 2013a). The presence of different 93 
species of insects might determine the speed and pattern of infection in different farms (Ayllón et 94 
al., 2014; Bessell et al., 2014). The main vectors are thought to be species in the obsoletus complex 95 
of Culicoides, or biting midges, including Culicoides chiopterus, dewulfi and scoticus (Balenghien 96 
et al., 2014; De Regge et al., 2012). Experimental studies with C. sonorensis (Veronesi et al., 2013), 97 
a known vector of bluetongue virus, have shown that these midges can also produce a competent 98 
infection and could act as a reservoir of the virus. Importantly, midges are most abundant between 99 
April and October, with a ‘peak midge season’ between July to September, which coincides with 100 
the peak of SBV seroconversion in 2012/2013 (Mellor et al., 2000; EFSA, 2012b; Larska et al., 101 
2013; Veldhuis et al., 2013). 102 
 103 
It is probable that SBV can overwinter in midges. Viral RNA has been detected in midges 104 
belonging to the obsoletus complex over-winter in north Italian farms 3 months after the SBV 105 
outbreak (Goffredo et al., 2013). Furthermore, these midges can become active at temperatures as 106 
low as 3.5°C (Sprygin et al., 2014). In Germany, it was reported that midges could be trapped 107 
during warmer (~9°C) winter days (Wernike et al., 2013c). SBV spread in winter does occur 108 
(Davies and Daly, 2013), but is likely to be limited as the threshold for replication of the virus 109 
appears to be between 12 and 13°C (Gubbins et al., 2014b).  110 
 111 
Wind also plays an important role in the transmission of the virus, as midges are easily 112 
carried on air currents. (Sedda et al., 2012; Sedda and Rogers, 2013). UK Meteorological office 113 
atmospheric dispersion models proved accurate at predicting SBV outbreaks due to midge spread. 114 
South-east, south and south-west counties in the UK were found at increased risk of outbreaks 115 
(Met-Office, 2012), from ‘midge plumes’ from mainland Europe. Wind models for midge dispersal 116 
in mainland Europe have also been used and have found that 70% of the spatial and temporal 117 
distribution of affected farms could be explained by wind movements (Sedda and Rogers, 2013).  118 
 119 
Clinical disease 120 
The main clinical disease seen in adult animals is fever, diarrhoea and, in the case of 121 
lactating animals, ‘milk drop’ syndrome. This is usually mild and self-limiting (Wernike et al., 122 
2012, 2013a, 2013b), however during the initial SBV outbreak due to the numbers of animals 123 
involved, there was a significant effect on farm level milk production (Toson et al., 2015; Veldhuis 124 
et al., 2014). Interestingly, neither field nor experimental infections produced clinical signs in adult 125 
sheep, goats or alpacas (Wernike et al., 2012, 2013a, 2013b; Poskin et al., 2014; Laloy et al., 2015; 126 
Schulz et al., 2015). The virus however readily crosses the placenta and has been isolated from the 127 
cerebrum, nerve and astroglial cells and spinal cords of lambs (Bilk et al., 2012; Varela et al., 128 
2013). After crossing the placenta, the virus infects and attacks the fetal central nervous system and 129 
the cerebral cortex, possibly causing necrosis (Agerholm et al., 2015). 130 
 131 
Since SBV targets these critical cells, the level of CNS development, and therefore the 132 
susceptible period of infection, determines the severity of lesions. Consistent with infection with 133 
other Bunyaviridae (Kurogi et al., 1977; Kirkland et al., 1988), infection in mid-gestation appears to 134 
be the defining factor causing these abnormalities. SBV infection from 60–180 days in cattle 135 
(Wernike et al., 2014) leads to severe dysplastic CNS lesions (Peperkamp et al., 2015). Infection 136 
during late pregnancy, when the CNS and the fetuses own immune system responses are more 137 
developed results in less severe clinical signs such as non-suppurative inflammation in the brain and 138 
spinal cord (Peperkamp et al., 2015). The typical arthrogryposis is thought to be a secondary 139 
clinical sign indicative of neuronal loss, leading to a muscle activity imbalance and a failure of 140 
normal muscle and joint development. This is supported by the fact that the virus is not found in the 141 
skeleton or muscle in fetuses (Bayrou et al., 2014; Peperkamp et al., 2015). 142 
 143 
Reports of early pregnancy loss (presenting as a failure to conceive) were a feature of the 144 
SBV outbreak. SBV infected sheep during the SBV outbreak in Belgium, had a doubling of 145 
abortions compared to non-infected flocks (Saegerman et al., 2014).  Similarly, SBV infected flocks 146 
from Ireland to Germany also had a 10–50% reduction in weaning rates reflecting both increased 147 
abortions and increased mortality during early lamb life ( Helmer et al., 2013; Wernike et al., 148 
2013b; Dominguez et al., 2014; Luttikholt et al., 2014; Barrett et al., 2015; Martinelle et al., 2015; 149 
Toson et al., 2015; Wüthrich et al., 2016). Some studies of affected dairy cattle herds have also 150 
demonstrated a detrimental impact in fertility parameters (including an increase in animals failing to 151 
conceive) during SBV outbreaks (Veldhuis et al., 2014) whereas others did not (Luttikholt et al., 152 
2014).  153 
 154 
Diagnosis 155 
The European Food Safety Authority released case definitions and diagnostic standards for 156 
SBV, which have been widely adopted by member states of the European Union (EFSA, 2012a, 157 
2012b). Suspect clinical cases include fetuses with two or more signs of arthrogryposis, 158 
hydranencephaly, spinal abnormalities such as kyphosis and scoliosis, joint malformation, limb 159 
paralysis and muscle atrophy (Afonso et al., 2014). Blindness and abnormal behaviour in neonates 160 
are also suspect signs. In adult animals, fever >40 °C, reduced appetite and milk drop (with no other 161 
apparent reason) can lead to suspicion of viral infection. 162 
 163 
Virus can be isolated in cell culture. However, RT-qPCR to detect viral RNA was generally 164 
used during the outbreak to confirm viral infection in fetuses or neonates. In adult animals, 165 
seropositivity has been detected by a variety of ELISA-based methods or with virus neutralisation 166 
tests (Loeffen et al., 2012; Breard et al., 2013; Afonso et al., 2014). Problems exist with either 167 
method for confirmation of the causality of the disease. For RT-qPCR assays, there is a narrow 168 
window of time where the virus can be detected in tissue/blood; fetuses with typical clinical signs of 169 
the disease may have cleared the virus before birth and therefore test negative on RT-qPCR. Most 170 
ELISA tests are not able to distinguish between different members of the Simbu serogroup of 171 
viruses, therefore serum neutralisation tests are required to definitively identify which virus an 172 
animal has been exposed to in regions where multiple viruses are circulating (Abutarbush et al., 173 
2015; Mathew et al., 2015).  Although serum neutralisation tests are more specific than ELISA, 174 
they are time consuming to perform and require cell culture facilities. These serological tests can 175 
confirm past infection but cannot give an indication of the timing of that infection in relation to the 176 
birth of an affected fetus (Bouwstra et al., 2013). Testing of the antibody response of the fetus (via 177 
fetal thoracic fluid testing) has been suggested as a more useful test for confirmation of SBV 178 
infection in deformed calves and lambs (De Regge et al., 2013).  179 
 180 
Herd level testing via bulk milk tank sampling was widely used at the height of the outbreak 181 
to confirm the geographical spread of the virus. There are, however, reports of herds with high 182 
values when bulk tank milk was tested by ELISA where the within-herd prevalence of antibodies is 183 
actually low (Tarlinton and Daly, 2013). Individually-sampled milk shows a strong correlation with 184 
serum results from the same animal, potentially providing a non-invasive method of determining 185 
within-herd exposure for dairy farms (Daly et al., 2015). Furthermore, detection of antibodies in 186 
saliva by ELISA provides another non-invasive, fast method to determine prevalence of antibodies 187 
(Lazutka et al., 2015).  188 
 189 
Control  190 
Attempts were made during the initial outbreak to limit midge numbers through 191 
environmental controls (insecticide dipping of animals, breaking up of manure from midge breeding 192 
sites). Chemical treatment of sheep has shown some promise in reducing numbers of midges 193 
(Weiher et al., 2014) however environmental control of midge breeding sites on farms has so far 194 
failed to impact on insect numbers (Harrup et al., 2014). The seemingly high replication efficiency 195 
and spread of SBV in Culicoides spp. especially when compared with bluetongue virus (BTV), 196 
(spread by the same main vectors) also limits the use of insect control methods in the control of 197 
SBV (EFSA, 2014; Veronesi et al., 2013) 198 
 199 
There have been three commercial vaccines released against the virus, all of which are 200 
adjuvanted inactivated (‘killed’) virus vaccines. The first vaccine available was brought to market in 201 
record time under a provisional registration, however the speed of introduction and licencing route 202 
has meant that comprehensive data on efficacy and safety in pregnant animals (a crucial group to 203 
protect) has not been available. In a study of prototype killed virus vaccines, onset of immunity in 204 
cattle and sheep was demonstrated three weeks after the second of two doses given three weeks 205 
apart (Wernike et al., 2013d). This type of vaccine appears to be effective in preventing viral 206 
replication in animals, with sheep protected when challenged 3 weeks after a single dose 207 
(Hechinger et al., 2014). Natural infection has been shown to induce persistent antibodies in 208 
infected cows, lasting at least 36 months (Elbers et al., 2014; Méroc et al., 2015, Wernike et al 209 
2015b). 210 
 211 
Anecdotal reports and the author’s observations have indicated that uptake of the 212 
commercial SBV vaccines has been low and the fact that none of the released vaccines are currently 213 
available (March 2017) would attest to this. Recent data in England showed that even though half of 214 
124 farmers surveyed suspected cases of SBV on their farm, only 13.7% had vaccinated in 2013, 215 
with that figure falling to 1.6% in 2014. One farm had vaccinated cattle but not sheep (Stokes et al., 216 
2016). There are a number of potential reasons for a lack of interest from farm managers in 217 
vaccinating against SBV. In our own unpublished data from surveys of UK farms in 2013 only one 218 
farm in 20 was planning on vaccinating for SBV. A recurrent theme in responses was the perception 219 
that SBV “would disappear like bluetongue” usually indicating that European farmers did not feel it 220 
was economically viable to maintain vaccination programmes for intermittent vector borne diseases. 221 
Indeed, in the Netherlands the circulation of the virus in 2013 was <1% with a low number of 222 
seropositive animals (Veldhuis et al., 2015). 223 
 224 
The two non-structural proteins (NSs, NSm) may play a role in viral pathogenesis (Eifan et 225 
al., 2013; Hart et al., 2009).  Experimental trials of live virus vaccines with the viral NSs and NSm 226 
protein genes deleted have demonstrated the efficacy and safety of such vaccines (Kraatz et al., 227 
2015). A crucial advantage of knockout mutants like this includes the ability to develop tests against 228 
the missing proteins to differentiate infected from vaccinated animals, an important issue in 229 
international trade considerations. These vaccines have however not been taken through to full 230 
commercialisation.  231 
 232 
The main other control method that has been advocated, apart from vaccinating before first 233 
mating, has been the moving of mating of sheep flocks and cattle herds to later in the autumn when 234 
midge numbers and virus circulation are lower. This should be effective in limiting reproductive 235 
effects in sheep flocks and cattle herds but is only practical in production systems that practice 236 
block matings (Helmer et al., 2013; Dominguez et al., 2014; Luttikholt et al., 2014; Poskin et al., 237 
2016). 238 
 239 
Economic impact of SBV  240 
The impact of the initial SBV outbreak on the overall European economy was low (EFSA, 241 
2012a). The cost to individual farm businesses shows great variation depending on whether their 242 
mating practices result in the at-risk gestation period overlapping with peak midge season. Several 243 
recent studies have considered the overall economic impacts of the virus (Dominguez et al., 2014; 244 
Martinelle et al., 2014; Veldhuis et al., 2014; Barrett et al., 2015) and there have been several 245 
economic models produced from this data (Alarcon et al., 2014; Raboisson et al., 2014). The main 246 
impacts of the virus on farm economics can be summed up as milk production losses, reproductive 247 
losses due to abortion and fetal deformity, the cost of purchase of replacement stock to compensate 248 
for reproductive losses, replacement animals not sold, as well as veterinary costs and movement 249 
restrictions (Alarcon et al., 2014).   250 
 251 
One factor the current models have not included is the impact of early reproductive losses as 252 
firm data is still not available on this. The inclusion of these losses would of course add to the 253 
economic impact of the virus for producers. These impacts need to be considered in the light of the 254 
very high variation in impact on individual farms, ranging from negligible to over 50% of losses of 255 
new-born animals (Helmer et al., 2013). It also needs to be considered in the light of the range of 256 
production systems for ruminants in Europe which vary from high genetic value, intensively 257 
managed, indoor housed year round reproduction dairy herds to extensively grazed, low stocking 258 
density, block mated in autumn, sheep flocks. 259 
 260 
One of the main economic impacts of the initial SBV outbreak was the loss of export 261 
markets for bovine genetics (semen, embryos and breeding stock) due to the introduction of trade 262 
barriers from countries free of SBV (60% of countries trading with Europe imposed restrictions). A 263 
decline of 10-20% in trade was observed in addition to the value of pure-bred breeding animal 264 
exports dropping by 20% from 2011 to 2012 (EFSA, 2014). The remaining outcome of economic 265 
significance has been the finding that potentially infectious virus is shed intermittently in semen for 266 
up to 3 months after initial infection in a small number of bulls (Hoffmann et al., 2012, 2013; 267 
Ponsart et al., 2014; Schulz et al., 2014; Van Der Poel et al., 2014). This has not been reported for 268 
rams or bucks, however only small numbers of sheep and goats have been examined compared with 269 
cattle. Sexual transmission of the virus has not been reported, however given the importance of 270 
artificial insemination in cattle breeding in developed countries the risk of virus introduction has 271 
resulted in trade bans or testing requirements on semen or embryos from SBV-affected areas 272 
(Hoffmann et al., 2012).  273 
 274 
In the light of the concerns of producers over vaccination cost and benefit and the current 275 
risk and uncertainty over future SBV outbreaks it is worth considering recent data on the economic 276 
impacts of the virus and the cost-benefits of vaccination as a control measure. Vaccination 277 
experience with bluetongue virus has shown that a high rate of vaccination can significantly reduce 278 
virus circulation and reduce the economic impact of the loss of animals (Lazutka et al., 2015). A 279 
brief summary of the range of the costs of the disease versus the cost of vaccination for the main 280 
production types in Europe is presented in Table 1 below. 281 
 282 
  These figures would indicate that vaccination would be warranted in most beef cattle herds 283 
and dairy sheep flocks, however in other production systems only those herds in “high risk” 284 
categories, such as a herd of low seropositivity, management systems where gestation and pasture 285 
availability overlaps with peak midge season (Baylis et al., 2010; Alarcon et al., 2014) would 286 
accrue an overall benefit from vaccination against SBV.   287 
 288 
Potential for SBV re-emergence 289 
Other viruses that infect ruminants, such as BTV in Europe, and related Bunyaviridae in 290 
Japan and Australia, have shown a pattern of re-emergence when certain conditions are met. It is 291 
therefore anticipated that SBV might follow the same pattern of re-emergence. In Japan there are 292 
epidemics of Aino virus every 3-6 years (Tsuda et al., 2004; Kono et al., 2008) as naïve animals 293 
become available. For Akabane virus in Australia there are predictable annual transmission patterns 294 
and outbreaks every 10-15 years, due to expansion or temporary contraction of the vector or 295 
movement of naïve animals. 296 
 297 
Bluetongue virus serotype 8 (BTV-8), which shares the same vector species as SBV, 298 
recently re-emerged in Europe after a period of absence of clinical disease of several years and 299 
declining seropositivity in the resident ruminant population (Sailleau et al., 2015; Bréard et al., 300 
2016). Loss of SBV immunity has already been seen in Germany with only about 20% of newborn 301 
animals having antibodies (Wernike et al., 2015a). In animals born since the initial outbreak, the 302 
numbers seroconverting have been much lower, 58–65.7% in adult animals and as low as 20.6% in 303 
heifers (Meroc et al., 2015; Wernike et al., 2015b), resulting in a drop of seropositivity (and 304 
presumably immunity). In the UK and Ireland no seroconversions were detected in 2014–15 305 
indicating a presumed absence of the disease there in those years (Collins et al., 2016a; Stokes et 306 
al., 2016).  307 
The virus has continued to circulate at a low level in continental Europe with detection in 308 
Germany (Wernike et al., 2015a) and Belgium (Delooz et al., 2016). Evidence of increased 309 
circulation has recently been seen in the Netherlands with outbreaks of diarrhoea in cattle linked to 310 
SBV reported (Promed Mail 2016).  Similarly, virus re-circulation has been evident in the UK in 311 
2016 with a number of reports of clinical cases and seroconversion (Unknown, 2016). It is possible 312 
that large scale resurgence could occur when a combination of the number of naïve replacement 313 
stock reaches a critical level together with favourable conditions for the vectors.  314 
 315 
It has also been proposed that local wild ruminant populations may be a reservoir for 316 
arboviruses as BTV virus was detected in red deer in Spain, while livestock was disease free (Ruio-317 
Fons et al., 2014). Similarly, SBV virus has also been found in roe deer (Diaz et al., 2015), the 318 
European bison (Krzysiak et al., 2016) and other species (reviewed in Tarlinton et al., 2013) raising 319 
the prospect of a wild-life SBV reservoir in Europe.  320 
 321 
SBV is not notifiable at the European level, however several individual countries have made 322 
it notifiable (including Germany, France, the Netherlands and Ireland) and hence have maintained 323 
active monitoring programmes. Using milk yield to monitor disease state has been suggested as 324 
syndromic surveillance for several diseases that affect ruminants (Madouasse et al., 2013,2014). In 325 
combination with testing milk for virus-specific antibodies, this could help identify areas where 326 
infection is occurring (Veldhuis et al., 2016). 327 
 328 
In both Australia and Japan arbovirus monitoring programmes of sentinel animals and 329 
midge trapping and testing are in place as early warning systems (Kirkland, 2004; Geoghegan et al., 330 
2014; Kato et al., 2015) and we, as well as others (Regge, 2016) would suggest that such a system 331 
in Europe would be warranted. In Ireland and France, which have instituted surveillance using 332 
Culicoides monitoring and sentinel herds or reporting by sentinel veterinarians this approach has 333 
been successful in detecting circulating virus and new cases in the recent re-emergence (Collins et 334 
al., 2016b, Gache et al., 2017).  335 
 336 
In Japan, sentinel herds are employed in the southernmost islands where the outbreaks are 337 
more likely to begin due to the warmer climate. Several vaccines are available and are deployed 338 
pro-actively if circulation is detected (Kurogi et al. 1979, Kono et al 2008; Kim et al. 2011, Kato et 339 
al., 2015). In Australia, even though there is no currently registered vaccine, the information gained 340 
from the early monitoring and warning systems allows the farmers to make decisions about moving 341 
their herds or delaying mating to avoid the teratogenic consequences of infection (reviewed in 342 
Kirkland, 2015). 343 
 344 
Such a programme Europe-wide would alert livestock holders of the potential for SBV 345 
disease impacts in advance of the main seasonal ruminant breeding activities in summer and autumn 346 
giving producers the opportunity to assess whether vaccination or delay of mating would be 347 
necessary for their herds and flocks. Ideally, improved data on midge abundance, virus circulation 348 
in midges and modelling of long term climate and land use variables that affect midge abundance 349 
would be necessary for advanced warning of the risk of disease, however without a substantial body 350 
of data from long term sentinel monitoring programmes on a continent wide basis such as that 351 
available in Australia (Bishop et al., 2000; Eagles et al., 2014) this cannot happen.  352 
 353 
In addition, the detection of numerous different Simbu-group viruses in the Mediterranean 354 
and Africa has made it clear that there are numerous viruses circulating in the regions where SBV is 355 
likely to have come from. This, combined with the well-studied propensity of this group of viruses 356 
to swap genetic segments (antigenic shift), makes it quite likely that there will be outbreaks of 357 
viruses with similar pathogenesis and epidemiology to SBV in Europe in the near future, making 358 
preparation of diagnostic and vaccine platforms transferrable across this virus group a priority.  359 
 360 
Conclusions 361 
While we now know much more about SBV than when it was initially reported, there are 362 
still a number of long-term uncertainties about the impact of the virus on the European ruminant 363 
herd. Chief among these is the long-term endemic stability of the viruses. From the currently 364 
available data, it is clear that the initial epidemic front of the virus in 2011–12 was the worst case 365 
scenario, with immunologically-naïve animals being exposed for the first time to the virus resulting 366 
in almost 100% seroconversion in some regions. Since 2013–14, there has been continuing low 367 
level circulation of SBV in Western Europe and overall herd immunity (variable to begin with) has 368 
dropped. This unfortunately increases the likelihood of repeated epidemic outbreaks, particularly in 369 
years when high midge numbers and susceptible ruminants coincide. 370 
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  895 
Table 1 
 Production 
System 
Cost range  of 
disease £/1000 
head 
Cost benefit of 
vaccination 
 
Likelihood 
of use 
Dairy cattle 8200 to 51400  -5720 to 37480 High risk 
only 
Beef cattle 18000 to 30650 4080 to 16730 Yes 
Lamb production 4750  to 20850  -9170 to 7000 High risk 
only 
Dairy Sheep 10340 to 29,810  3580 to 15890 Yes 
Cost of the disease per 1000 animal vs. cost benefit of vaccination (adapted from Raboisson et al. 896 
(2014). Costs are shown for high risk and low risk cases and exclude labour costs. Vaccination cost 897 
assumed at UK £13.92 per head (£13920 per herd) (Price as of Dec 2015“farmacy”website 1) 898 
(£1UK= approximately US $1.23, €1.16 as of 18th Nov 2016) 899 
                                                 
1 “Farmacy” website: http://www.farmacy.co.uk/categories/575-schmallenberg (accessed 22nd March 2017)  
